Avance Clinical, a full‑service CRO with more than 30 years of experience, will attend BIO CHINA 2026, a premier gathering of global biotech innovators and scientific leaders.
Meet with us in Suzhou 12–14 March to learn how Avance Clinical supports faster, globally aligned clinical development through integrated early‑phase and multi‑region capabilities.
Our robust operational presence across Asia enables biotechs to run coordinated, multi‑region clinical programs across all phases.
For Chinese biotechs:
For North American and European biotechs:
At BIO China, discover how our Asia Advantage delivers speed, scalability, and global‑ready data quality, backed by the scientific and medical expertise that supports biotechs through every stage of early development.
Recognized as Australia’s leading early‑phase CRO, Avance Clinical supports biotechs with fast, globally aligned early‑phase development pathways. Australia’s clinical research environment provides several unique advantages, including:
Avance Clinical leverages these advantages to help biotechs reach proof‑of‑concept sooner, manage costs effectively, and transition smoothly into global later‑phase programs.
Connect with us during BIO CHINA to explore how Avance Clinical can accelerate your pathway from early‑phase trials to global development success.
Avance Clinical is a full-service Contract Research Organization (CRO) with clinical operations in Australia, New Zealand, Asia, North America, and Europe.
Level 22, 91 King William Street
Adelaide, SA
Australia 5000
Phone: +61 8 8249 4788
For all media enquiries: media@avancecro.com
